Sarepta Therapeutics

FDA

Pharma

FDA investigates 2 deaths after Sarepta Duchenne gene therapy

The agency is investigating two Duchenne muscular dystrophy patient deaths following treatment with Sarepta Therapeutics’ Elevidys.

Angus Liu Jun 25, 2025 10:26am

2nd patient dies after Sarepta's DMD gene therapy Elevidys

Jun 16, 2025 10:58am

Collage poster study of businessmen picture chart arrow goes up

Novartis, Sarepta tipped to drive genomic therapy sales boom

May 15, 2025 12:18pm

pause button on blue background

Sarepta sees delays in treatment after Elevidys death report

May 7, 2025 8:03am

thunderstorm road

Patient dies after receiving Sarepta's DMD gene therapy Elevidys

Mar 18, 2025 10:34am

Sarepta Sarepta Therapeutics

Sarepta's Elevidys blows sales expectations out of the water

Nov 7, 2024 3:43pm